Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol-Myers Squibb's has become the first company to bring a cardiac myosin inhibitor through to FDA approval, claiming a green light from the US regulator for mavacamten as a therapy for ...

Smart rings represent the most exciting and fastest-moving area of wearables, with the top options offering accurate health tracking, sleep monitoring, and stress insights. The market boomed last year ...

After the ordnance was discovered, 18,000 people evacuated from the city. Experts worked for several hours to safely dispose of the device One researcher wrote a 600-page report attributing an obscure ...